Acute Kidney Injury in Pediatric Patients Treated with Vancomycin and Piperacillin-Tazobactam Versus Vancomycin and Cefotaxime: A Single-center Study

Background Previous literature showed a higher incidence of acute kidney injury (AKI) in pediatric patients using vancomycin + piperacillin-tazobactam compared to cefepime + vancomycin. Our aim was to compare the incidence of developing AKI during the use of vancomycin + cefotaxime with that during...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cureus
Glavni autori: Alqurashi, Rewaa, Batwa, Mawaddah, Alghamdi, Bashayer, Aljohani, Saja, Zaher, Nada, Alzahrani, Amal, Aldigs, Eman, Safdar, Osama
Format: Artigo
Jezik:Inglês
Izdano: Cureus 2020
Teme:
Pediatrics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7047341/
https://ncbi.nlm.nih.gov/pubmed/32140363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.6805
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items